![]() Exscientia Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery. | ||
Founding Date | Founding Date 2012 | Founding Date 2003 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Oxford, GB HQ Wien, AT Osaka, JP Dundee, GB Miami, US | Locations Modi'in-Maccabim-Re'ut, IL HQ |
Employees | Employees 88 | Employees 2414% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) £20.1m (FY, 2023) | Revenue (est.) $1.2m (FY, 2025) |
Cost of goods | Cost of goods £10.5m (FY, 2023) | Cost of goods $230k (FY, 2025) |
Gross profit | Gross profit £10.8m (FY, 2023) | Gross profit $950k (FY, 2025) |
Net income | Net income (£146m) (FY, 2023) | Net income ($2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 430.2m | Total funding raised $ 100.9m |

BioLineRx is a biopharmaceutical company focused on oncology.
View company